Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis
D. G. Couch, Henry Maudslay, Brett Doleman, et al.
Inflammatory Bowel Diseases (2018) Vol. 24, Iss. 4, pp. 680-697
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history
Sara Anna Bonini, Marika Premoli, Simone Tambaro, et al.
Journal of Ethnopharmacology (2018) Vol. 227, pp. 300-315
Closed Access | Times Cited: 571
Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
Vicente Martı́nez, Amaia Iriondo‐DeHond, Francesca Borrelli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3067-3067
Open Access | Times Cited: 143
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Marco Solmi, Marco De Toffol, Jong Yeob Kim, et al.
BMJ (2023), pp. e072348-e072348
Open Access | Times Cited: 117
Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo—A Randomized, Placebo-controlled, Double-blind Controlled Trial
D. G. Couch, Hollie Cook, Catherine A. Ortori, et al.
Inflammatory Bowel Diseases (2019) Vol. 25, Iss. 6, pp. 1006-1018
Open Access | Times Cited: 88
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
Gemma Navarro, Katia Varani, Alejandro Lillo, et al.
Pharmacological Research (2020) Vol. 159, pp. 104940-104940
Open Access | Times Cited: 77
Review: Cannabinoids as Medicinals
Jag Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 42
Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives
Fabrizio Calapai, Luigi Cardia, Emanuela Esposito, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 42
The therapeutic potential of purified cannabidiol
Saoirse E. O’Sullivan, Sanne Jensen, Gitte Nykjaer Nikolajsen, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 29
The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review
Eman A. Alraddadi, Faisal F. Aljuhani, Ghadah Y. Alsamiri, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
Tim Ambrose, Alison Simmons
Journal of Crohn s and Colitis (2018) Vol. 13, Iss. 4, pp. 525-535
Open Access | Times Cited: 61
Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence
Madison Wright, Patricia Di Ciano, Bruna Brands
Cannabis and Cannabinoid Research (2020) Vol. 5, Iss. 3, pp. 191-196
Open Access | Times Cited: 61
Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
Melanie Kienzl, Martin Storr, Rudolf Schicho
Clinical and Translational Gastroenterology (2020) Vol. 11, Iss. 1, pp. e00120-e00120
Open Access | Times Cited: 54
Phytocannabinoid Pharmacology: Medicinal Properties of Cannabis sativa Constituents Aside from the “Big Two”
Peter B. Sampson
Journal of Natural Products (2020) Vol. 84, Iss. 1, pp. 142-160
Closed Access | Times Cited: 50
Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
Cristian Scheau, Constantin Căruntu, Ioana Anca Bădărău, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 6, pp. 494-494
Open Access | Times Cited: 49
Dietary Cannabidiol Activates PKA/AMPK Signaling and Attenuates Chronic Inflammation and Leaky Gut in DSS‐Induced Colitis Mice
Qi Sun, Alejandro Bravo Iniguez, Qiyu Tian, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 4
Open Access | Times Cited: 6
Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis
Cristoforo Silvestri, Ester Pagano, Sébastien Lacroix, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 49
Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double‐blind randomised controlled trials
Grainne Holleran, Franco Scaldaferri, Antonio Gasbarrini, et al.
Phytotherapy Research (2019) Vol. 34, Iss. 1, pp. 77-93
Closed Access | Times Cited: 48
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
Rafael Franco, Rafael Rivas‐Santisteban, Irene Reyes‐Resina, et al.
Pharmacological Research (2020) Vol. 158, pp. 104801-104801
Closed Access | Times Cited: 40
The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information
Arun Swaminath, Eric P Berlin, Adam S. Cheifetz, et al.
Inflammatory Bowel Diseases (2018) Vol. 25, Iss. 3, pp. 427-435
Open Access | Times Cited: 42
A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease
Benthe H. Doeve, Maartje M. van de Meeberg, Fiona D. M. van Schaik, et al.
Journal of Clinical Gastroenterology (2020) Vol. 55, Iss. 9, pp. 798-809
Closed Access | Times Cited: 36
Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease
Jonathan Gotfried, Timna Naftali, Ron Schey
Gastroenterology (2020) Vol. 159, Iss. 1, pp. 62-80
Open Access | Times Cited: 35
Antioxidant and Anti-Inflammatory Phytochemicals for the Treatment of Inflammatory Bowel Disease: A Systematic Review
George M. Pantalos, Natalia Vaou, Smaragda Papachristidou, et al.
Applied Sciences (2024) Vol. 14, Iss. 5, pp. 2177-2177
Open Access | Times Cited: 4
Characterisation of components of an extract of hemp and preliminary assessment of anti-inflammatory activity in an ex vivo model of bovine endometritis
Ifat Parveen, Nathan R. Allen, Ruth Wonfor, et al.
South African Journal of Botany (2025) Vol. 180, pp. 254-264
Open Access
Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB1, TRPV1, and PPARα
Mustafa Karwad, D. G. Couch, Karen L. Wright, et al.
Biochemical Pharmacology (2019) Vol. 168, pp. 465-472
Open Access | Times Cited: 31
Cannabinoids, interoception, and anxiety
Allyson K. Andrade, Briana Renda, Jennifer E. Murray
Pharmacology Biochemistry and Behavior (2019) Vol. 180, pp. 60-73
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top